New MRI dye could spot aggressive brain tumors without surgery
NCT ID NCT06014905
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a special MRI technique that uses a substance called hyperpolarized pyruvate to see how active a meningioma brain tumor is. About 50 adults with known or suspected meningioma will get an IV of this substance before an MRI scan. The goal is to see if this method can safely and reliably tell aggressive tumors from slow-growing ones, which could help avoid unnecessary biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hyperpolarized carbon C 13 pyruvate
What this could lead to
If successful, this imaging method could help doctors identify aggressive meningiomas without needing a biopsy, guiding treatment decisions more quickly.
What could go wrong
This is a very early pilot study with only 50 participants, so it may not work for everyone. The technique is still experimental and not yet proven to be better than standard scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••